TY - JOUR
T1 - What I have changed my mind about and why
AU - Yehuda, Rachel
AU - Spiegel, David
AU - Southwick, Steven
AU - Davis, Lori L.
AU - Neylan, Thomas C.
AU - Krystal, John H.
N1 - Publisher Copyright:
© 2016 Rachel Yehuda et al.
PY - 2016
Y1 - 2016
N2 - This paper is based upon a panel discussion ‘‘What I Have Changed My Mind About and Why’’ held on 5 November in New Orleans, Louisiana (USA), as part of the ISTSS 2015 annual meeting ‘‘Back to Basics: Integrating Clinical and Scientific Knowledge to Advance the Field of Trauma.’’ The panel was chaired by Professor Dr. Rachel Yehuda of the Icahn School of Medicine at Mount Sinai and the James J. Peters Veterans Affairs, and included five clinician-scholars who exchanged thoughts about what they have changed their minds about over the years: Dr. David Spiegel, Dr. Steven Southwick, Dr. Lori Davis, Dr. Thomas Neylan, and Dr. John Krystal. This paper provides a summary of the salient points made by each expert and the questions and discussion that ensured. Major issues raised included the increasingly clear limitations to the fear-based model that has advanced the field. While treatments for PTSD have improved, there are some aspects of trauma exposure that cannot be entirely repaired. Research providing an evidence base to treatment has led to overly specific treatment guidelines that may obscure more general principles of effective treatment. Treatment might be viewed as a way to increase the plasticity of the brain in the context of processing social cues. A variety of novel and integrative therapies include comprehensive holistic care, exercise, returning to competitive work, logotherapy, mindfulness, enhancing well-being and resilience, and medications with novel mechanisms, such as ketamine.
AB - This paper is based upon a panel discussion ‘‘What I Have Changed My Mind About and Why’’ held on 5 November in New Orleans, Louisiana (USA), as part of the ISTSS 2015 annual meeting ‘‘Back to Basics: Integrating Clinical and Scientific Knowledge to Advance the Field of Trauma.’’ The panel was chaired by Professor Dr. Rachel Yehuda of the Icahn School of Medicine at Mount Sinai and the James J. Peters Veterans Affairs, and included five clinician-scholars who exchanged thoughts about what they have changed their minds about over the years: Dr. David Spiegel, Dr. Steven Southwick, Dr. Lori Davis, Dr. Thomas Neylan, and Dr. John Krystal. This paper provides a summary of the salient points made by each expert and the questions and discussion that ensured. Major issues raised included the increasingly clear limitations to the fear-based model that has advanced the field. While treatments for PTSD have improved, there are some aspects of trauma exposure that cannot be entirely repaired. Research providing an evidence base to treatment has led to overly specific treatment guidelines that may obscure more general principles of effective treatment. Treatment might be viewed as a way to increase the plasticity of the brain in the context of processing social cues. A variety of novel and integrative therapies include comprehensive holistic care, exercise, returning to competitive work, logotherapy, mindfulness, enhancing well-being and resilience, and medications with novel mechanisms, such as ketamine.
KW - PTSD
KW - alternative treatments
KW - evidenced based treatments
KW - fear extinction
KW - mindfulness
KW - neurobiology
KW - novel approaches
KW - pharma-cotherapy
KW - randomized clinical trials
KW - resilience
UR - http://www.scopus.com/inward/record.url?scp=85027719093&partnerID=8YFLogxK
U2 - 10.3402/EJPT.V7.33768
DO - 10.3402/EJPT.V7.33768
M3 - Article
AN - SCOPUS:85027719093
SN - 2000-8066
VL - 7
JO - European Journal of Psychotraumatology
JF - European Journal of Psychotraumatology
IS - 1
M1 - 33768
ER -